tiprankstipranks
Trending News
More News >
OSE Immunotherapeutics SA (DE:6OP)
FRANKFURT:6OP
Germany Market

OSE Immunotherapeutics SA (6OP) Stock Forecast & Price Target

Compare
1 Followers
See the Price Targets and Ratings of:

6OP Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
OSE
Immunotherapeutics SA
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

6OP Stock 12 Month Forecast

There Are No Analyst Ratings for DE:6OP In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

6OP Financial Forecast

6OP Earnings Forecast

The previous quarter’s earnings for 6OP were -€0.68.
The previous quarter’s earnings for 6OP were -€0.68.

6OP Sales Forecast

The previous quarter’s earnings for 6OP were €1.32M.
The previous quarter’s earnings for 6OP were €1.32M.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Kepler Capital  Analyst forecast on DE:6OP
Kepler Capital
Kepler Capital
€12.5
Buy
144.14%
Upside
Reiterated
09/12/25
OSE Immunotherapeutics SA (6OP) Receives a Buy from Kepler Capital
H.C. Wainwright Analyst forecast on DE:6OP
H.C. Wainwright
H.C. Wainwright
€14
Buy
173.44%
Upside
Reiterated
05/07/25
Promising Clinical Trial Results and Strategic Positioning Propel OSE Immunotherapeutics SA to a Buy Rating
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Kepler Capital  Analyst forecast on DE:6OP
Kepler Capital
Kepler Capital
€12.5
Buy
144.14%
Upside
Reiterated
09/12/25
OSE Immunotherapeutics SA (6OP) Receives a Buy from Kepler Capital
H.C. Wainwright Analyst forecast on DE:6OP
H.C. Wainwright
H.C. Wainwright
€14
Buy
173.44%
Upside
Reiterated
05/07/25
Promising Clinical Trial Results and Strategic Positioning Propel OSE Immunotherapeutics SA to a Buy Rating
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering OSE Immunotherapeutics SA

3 Months
xxx
Success Rate
11/25 ratings generated profit
44%
Average Return
+3.34%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 44.00% of your transactions generating a profit, with an average return of +3.34% per trade.
1 Year
Nicolas PauillacKepler Capital
Success Rate
11/25 ratings generated profit
44%
Average Return
+16.50%
reiterated a buy rating 5 months ago
Copying Nicolas Pauillac's trades and holding each position for 1 Year would result in 44.00% of your transactions generating a profit, with an average return of +16.50% per trade.
2 Years
xxx
Success Rate
13/25 ratings generated profit
52%
Average Return
+3.04%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 52.00% of your transactions generating a profit, with an average return of +3.04% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

6OP Analyst Recommendation Trends

Rating
Jun 25
Sep 25
Oct 25
Nov 25
Jan 26
Strong Buy
6
5
3
1
0
Buy
0
0
13
13
13
Hold
0
0
8
14
20
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
6
5
24
28
33
In the current month, 6OP has received 13 Buy Ratings, 20 Hold Ratings, and 0 Sell Ratings. 6OP average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

6OP Stock Forecast FAQ

What is DE:6OP’s average 12-month price target, according to analysts?
Currently, no data Available
What is DE:6OP’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:6OP, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is OSE Immunotherapeutics SA a Buy, Sell or Hold?
      Currently, no data Available
      What is OSE Immunotherapeutics SA’s share price target?
      Currently, no data Available
      What do analysts say about OSE Immunotherapeutics SA?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of OSE Immunotherapeutics SA?
      To buy shares of DE:6OP, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.